CHRISTINA BUZIS: Open Payments
NPI 1154894962 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 27 payments from 14 companies in 2025. Trend: 2023 $139 · 2024 $1,462 · 2025 $849
Food & beverage: $523Education: $326
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $272 |
| SANOFI-AVENTIS U.S. LLC | 2 | $136 |
| ANI Pharmaceuticals, Inc. | 4 | $108 |
| Eisai Inc. | 5 | $99 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Averitas Pharma Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $21 |
| Electromed, Inc. | 1 | $20 |
Products named: DUPIXENT, PURIFIED CORTROPHIN GEL, Leqembi, NUCALA, INGREZZA, WINREVAIR, QUTENZA, UBRELVY.
Industry payments across AZ — which companies pay providers there.
